Edward White

Stock Analyst at HC Wainwright & Co.

(0)
# 4743
Out of 5,337 analysts
518
Total ratings
22.19%
Success rate
-20.98%
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
CGEM Cullinan Therapeutic...
Reiterates: Buy
33 33
6.95 374.82% 24 Apr 16, 2025
VALN Valneva
Reiterates: Buy
17 17
6.15 176.42% 41 Apr 15, 2025
INZY Inozyme Pharma
Reiterates: Buy
16 16
1.47 988.44% 14 Apr 10, 2025
NYXH Nyxoah
Reiterates: Buy
15 15
6.23 140.77% 15 Apr 8, 2025
SABS SAB Biotherapeutics
Reiterates: Buy
6 6
1.96 206.12% 15 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 16
1.99 704.02% 18 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 11 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
0.34 1076.47% 6 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 11 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
1.92 941.67% 2 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
15 16
1.77 803.95% 7 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 25
5.17 383.56% 6 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
1.8 344.44% 25 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 2 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 23 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 11
n/a n/a 18 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
55 55
33.72 63.11% 31 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 51
8.72 484.86% 29 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
2.95 137.29% 20 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 56
5.03 1013.32% 28 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
31 31
9.44 228.39% 21 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5 5
n/a n/a 15 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 12 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 3
n/a n/a 13 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 9 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25
n/a n/a 7 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101 52
n/a n/a 4 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 20
n/a n/a 4 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
168 180
n/a n/a 7 Sep 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
0.31 8932.26% 3 Aug 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 30
17.2 74.42% 5 Aug 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
251 247
n/a n/a 14 Aug 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 15
n/a n/a 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
13 20
n/a n/a 1 Dec 10, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 26, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12
0.99 1112.12% 2 Mar 6, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
158
n/a n/a 3 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
n/a n/a 1 May 24, 2017